Molecular Heterogeneity and Response to Neoadjuvant Human Epidermal Growth Factor Receptor 2 Targeting in CALGB 40601, a Randomized Phase III Trial of Paclitaxel Plus Trastuzumab With or Without Lapatinib.
| Image |  |
|---|---|
| Description | scientific article |
| Author/s |
author: Charles M. Perou Carey K Anders Katherine A. Hoadley Ian E Krop Brandelyn N Pitcher Constance T Cirrincione Clifford A Hudis Maggie Chon U Cheang Eric Winer |
| Publication date | November 2, 2015 |
| Language | English |
| Country of origin | |
| Wikipedia link | |
| Copyright status | |
| Missing/wrong data? | Edit Wikidata item |